GLP-1s
The New Weight-Loss Problem Isn’t Access. It’s Burnout, Survey Finds
Weight loss is a top priority for Americans amid the rise of GLP-1s, but rising emotional strain suggests the system is starting to crack
Weight Watchers Goes All-In on GLP-1s With App Overhaul
The new Weight Watchers app combines GLP-1 prescriptions with personalized nutrition tools, coaching and strength training offerings.
Noom Eyes GLP-1s for Longevity, Not Just Weight Loss
Noom’s microdose GLP-1 program targets early metabolic risk and longevity, offering weight-loss drugs to adults with a BMI of 21 or higher.
Bodd Lands $15M for Body-Scanning Tech, With an Eye Toward GLP-1 Users
Bodd has raised $15 million to expand its body-scanning tech into the U.S. and U.K. while preparing pharmacy deployments for GLP-1 users.
Fitness Stakeholders Urge Strength Training for GLP-1 Users
Les Mills and ukactive are urging the healthcare and fitness sectors to promote strength training and adequate protein intake for people taking weight-loss drugs.
Beyond Botox: Med-Spas Find Their Next Chapter in Longevity
Med-spas are evolving into longevity clinics as GLP-1 users and wellness consumers seek regenerative treatments.
GLP-1s Could Reduce US Deaths by 9% in Best Case Scenario, Report Finds
Anti-obesity medications like GLP-1s have the potential to significantly reduce mortality in countries across the globe, per a new report.
HFA Backs Trump’s GLP-1 Medicare Expansion, Urges Exercise Coverage
The Health & Fitness Association has praised the expansion of Medicare to cover GLP-1 drugs and calls for the coverage of exercise programs.
GLP-1 Use Doubles Across America — Here’s Who’s Taking Them
New Gallup data shows GLP-1 use has doubled nationwide as telehealth startups and investors are reshaping the weight-loss market.
WeightWatchers, Amazon Team Up for Fast-Tracked Weight-Loss Meds
WeightWatchers has teamed with Amazon Pharmacy to simplify access to GLP-1 weight-loss drugs with real-time stock updates and home delivery.
